ALLcrimesfood&drugstaxestelecomcommercehealthconservationtransportationagricultureveteransbrowse all titles »
0

21 U.S.C. § 379rNational uniformity for nonprescription drugs

submitted 88 years ago by Pub. L. 105-115 to r/title-21-FOOD-AND-DRUGS · 598 words · no verdicts yet

in plain englishAI-generated · not legal advice

States generally can't make their own rules for nonprescription drugs that differ from federal ones. But there are exceptions, including a process for states to request an exemption from the FDA.

(a) In general. Except as allowed under subsections (b), (c)(1), (d), (e), or (f), a state or local government cannot create or keep in effect a requirement that (1) covers a drug that does not need a prescription (a drug not covered by section 353(b)(1) or 353(f)(1)(A)), and (2) is different from, adds to, or is not identical with a requirement under this chapter, the Poison Prevention Packaging Act of 1970, or the Fair Packaging and Labeling Act. (b) Exemption. (1) A state or local government can apply to the Secretary for an exemption from subsection (a). After giving notice and a chance for written and oral comment, the Secretary may grant the exemption, with conditions, if the state or local requirement: (A) protects an important public interest that federal law would otherwise leave unprotected, including the health and safety of children; (B) would not make any drug violate an applicable federal requirement or prohibition; and (C) would not unduly burden interstate commerce. (2) The Secretary must decide on an exemption application within 120 days of receiving it. (c) Scope. (1) This section does not apply to: (A) a state or local requirement about the practice of pharmacy; or (B) a state or local requirement that a drug can only be given out with a prescription from a licensed practitioner. (2) For subsection (a), a "requirement that relates to the regulation of a drug" includes any requirement about public information or other public communication that involves a warning about the drug. (d) Exceptions. (1) For a drug not covered by an approved application under section 355 or 357 (as section 357 stood before November 21, 1997), and not covered by a final order under section 355h finding it generally recognized as safe and effective, subsection (a) only blocks a state or local requirement that covers the same subject as — but differs from, adds to, or is not identical with — (A) a regulation or order in effect for the drug under one of the laws named in (a)(2); or (B) another requirement in effect for the drug because of an amendment to one of those laws made on or after November 21, 1997. (2) This section does not apply to a state requirement adopted through a public initiative or referendum enacted before September 1, 1997. (e) No effect on product liability law. Nothing in this section changes or affects any lawsuit or a person's liability under a state's product liability law. (f) State enforcement authority. Nothing in this section stops a state or local government from enforcing, under its own civil or other enforcement powers, a requirement that is identical to a requirement of this chapter.
the actual law source: uscode.house.gov ↗public domain
(a) In general

Except as provided in subsection (b), (c)(1), (d), (e), or (f), no State or political subdivision of a State may establish or continue in effect any requirement—

(1)

that relates to the regulation of a drug that is not subject to the requirements of section 353(b)(1) or 353(f)(1)(A) of this title; and

(2)

that is different from or in addition to, or that is otherwise not identical with, a requirement under this chapter, the Poison Prevention Packaging Act of 1970 (15 U.S.C. 1471 et seq.), or the Fair Packaging and Labeling Act (15 U.S.C. 1451 et seq.).

(b) Exemption
(1) In general

Upon application of a State or political subdivision thereof, the Secretary may by regulation, after notice and opportunity for written and oral presentation of views, exempt from subsection (a), under such conditions as may be prescribed in such regulation, a State or political subdivision requirement that—

(A)

protects an important public interest that would otherwise be unprotected, including the health and safety of children;

(B)

would not cause any drug to be in violation of any applicable requirement or prohibition under Federal law; and

(C)

would not unduly burden interstate commerce.

(2) Timely action

The Secretary shall make a decision on the exemption of a State or political subdivision requirement under paragraph (1) not later than 120 days after receiving the application of the State or political subdivision under paragraph (1).

(c) Scope
(1) In general

This section shall not apply to—

(A)

any State or political subdivision requirement that relates to the practice of pharmacy; or

(B)

any State or political subdivision requirement that a drug be dispensed only upon the prescription of a practitioner licensed by law to administer such drug.

(2) Safety or effectiveness

For purposes of subsection (a), a requirement that relates to the regulation of a drug shall be deemed to include any requirement relating to public information or any other form of public communication relating to a warning of any kind for a drug.

(d) Exceptions
(1) In general

In the case of a drug described in subsection (a)(1) that is not the subject of an application approved under section 355 of this title or section 357 of this title (as in effect on the day before November 21, 1997) or a final order under section 355h of this title by the Secretary establishing conditions under which the drug is generally recognized as safe and effective, subsection (a) shall apply only with respect to a requirement of a State or political subdivision of a State that relates to the same subject as, but is different from or in addition to, or that is otherwise not identical with—

(A)

a regulation or order in effect with respect to the drug pursuant to a statute described in subsection (a)(2); or

(B)

any other requirement in effect with respect to the drug pursuant to an amendment to such a statute made on or after November 21, 1997.

(2) State initiatives

This section shall not apply to a State requirement adopted by a State public initiative or referendum enacted prior to September 1, 1997.

(e) No effect on product liability law

Nothing in this section shall be construed to modify or otherwise affect any action or the liability of any person under the product liability law of any State.

(f) State enforcement authority

Nothing in this section shall prevent a State or political subdivision thereof from enforcing, under any relevant civil or other enforcement authority, a requirement that is identical to a requirement of this chapter.

Source credit: (June 25, 1938, ch. 675, § 751, as added Pub. L. 105–115, title IV, § 412(a), Nov. 21, 1997, 111 Stat. 2373; amended Pub. L. 116–136, div. A, title III, § 3851(c), Mar. 27, 2020, 134 Stat. 454.)

history & why it existsrecord from the source credit
  • 1938Enacted · Pub. L. 105-115 · 111 Stat. 2373
  • 2020Amended · Pub. L. 116-136 · 134 Stat. 454

A history note hasn’t been published yet. The record shows enactment by Pub. L. 105-115 on 1938-06-25.

all 0 arguments · sorted by: best

0/280

no arguments yet — make the first case